News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
178,406 Results
Type
Article (17209)
Company Profile (125)
Press Release (161072)
Section
Business (58341)
Career Advice (919)
Deals (9399)
Drug Delivery (30)
Drug Development (23291)
Employer Resources (70)
FDA (2319)
Job Trends (4221)
News (92242)
Policy (5818)
Tag
Academia (485)
Africa (326)
Alliances (16196)
Alzheimer's disease (334)
Antibody-drug conjugate (ADC) (39)
Approvals (2282)
Arizona (23)
Artificial intelligence (36)
Asia (13539)
Australia (2598)
Bankruptcy (75)
Best Places to Work (2797)
Biotechnology (113)
C2C Services and Suppliers (8012)
California (720)
Canada (325)
Cancer (186)
Career advice (740)
CAR-T (34)
Cell therapy (75)
China (60)
Clinical research (17660)
Collaboration (83)
Connecticut (28)
COVID-19 (708)
Cystic fibrosis (26)
Data (92)
Diagnostics (1005)
Diversity, equity & inclusion (21)
Earnings (15306)
Employer resources (67)
Europe (29327)
Events (30151)
Executive appointments (81)
FDA (2360)
Florida (68)
Funding (70)
Gene editing (21)
Gene therapy (54)
GLP-1 (212)
Government (587)
Healthcare (2401)
Hotbed/Location (114457)
Illinois (71)
Indiana (44)
Infectious disease (715)
Inflammatory bowel disease (42)
Interviews (132)
IPO (4036)
Job creations (1470)
Job search strategy (695)
Layoffs (119)
Legal (1178)
Lung cancer (38)
Management (21)
Manufacturing (40)
Maryland (115)
Massachusetts (539)
Medical device (706)
Medtech (707)
Mergers & acquisitions (5343)
Metabolic disorders (86)
Michigan (42)
Minnesota (76)
Neuroscience (402)
New Jersey (214)
New York (192)
NextGen Class of 2024 (1458)
Non-profit (486)
North Carolina (196)
Northern California (303)
Obesity (46)
Ohio (30)
Opinion (157)
Patents (30)
Pennsylvania (188)
People (21609)
Phase I (6846)
Phase II (8436)
Phase III (4778)
Pipeline (40)
Policy (27)
Postmarket research (298)
Preclinical (2777)
Press Release (63)
Rare diseases (61)
Real estate (2443)
Recruiting (35)
Regulatory (4273)
Research institute (526)
Resumes & cover letters (147)
Series A (23)
South America (400)
Southern California (310)
Startups (1781)
Texas (57)
United States (2853)
Vaccines (138)
Washington State (172)
Weight loss (50)
Date
Today (32)
Last 7 days (259)
Last 30 days (844)
Last 365 days (13082)
2024 (9251)
2023 (13342)
2022 (16152)
2021 (17029)
2020 (13265)
2019 (9687)
2018 (7718)
2017 (9039)
2016 (8194)
2015 (9492)
2014 (9758)
2013 (9496)
2012 (6126)
2011 (6505)
2010 (5885)
178,406 Results for "nanjing legend biotech".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Legend Biotech to Participate in the Jefferies Global Healthcare Conference
Legend Biotech Corporation today announced that Ying Huang, Ph.D., the company’s Chief Executive Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference in New York, NY on Thursday, June 6, 2024, at 10:30 a.m. ET.
May 29, 2024
·
1 min read
Business
Legend Biotech Reports First Quarter 2024 Results and Recent Highlights
Legend Biotech Corporation, a global leader in cell therapy, reported its first quarter 2024 unaudited financial results and key corporate highlights.
May 13, 2024
·
11 min read
Drug Development
Legend Biotech Shares Data on the Earliest Use to Date of CARVYKTI® in the Treatment of Multiple Myeloma and Important Subgroup Analyses at ASCO and EHA
Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, announced today results for the first time from the Phase 2 CARTITUDE-2 Cohort D study in multiple myeloma patients.
June 3, 2024
·
31 min read
Drug Development
J&J, Legend’s Phase III Win Cements Carvykti as Earlier-Line Multiple Myeloma Treatment
Johnson & Johnson and Legend Biotech’s Carvykti cell therapy significantly improved survival in patients with multiple myeloma when used in the second-line setting, the companies announced on Tuesday.
July 3, 2024
·
2 min read
·
Tristan Manalac
BioCapital
MaxCyte Signs Strategic Platform License Agreement with Legend Biotech to Accelerate Cell Therapy Discovery and Development
MaxCyte, Inc. announced it has entered into a strategic platform license agreement with Legend Biotech, a global leader in cell therapy.
May 22, 2024
·
7 min read
Pharm Country
Legend Biotech to Host Investor Conference Call on First Quarter 2024 Results
Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 am ET on Monday, May 13, 2024, to review first-quarter 2024 results.
April 11, 2024
·
1 min read
Pharm Country
Legend Biotech to Highlight Leadership in CAR-T Cell Therapy for Patients with Multiple Myeloma at ASCO and EHA
Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, announced today that new and updated data from the CARTITUDE clinical development program evaluating CARVYKTI® (ciltacabtagene autoleucel; cilta-cel) for patients with multiple myeloma will be presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting and the 2024 European Hematology Association’s (EHA) Hybrid Congress.
May 23, 2024
·
28 min read
Pharm Country
Legend Biotech Announces Publication of Inaugural Environmental, Social and Governance (ESG) Report
Legend Biotech Corporation today released its inaugural Environmental, Social & Governance (ESG) report.
March 19, 2024
·
5 min read
Business
Legend Biotech Reports Fourth Quarter and Full Year 2023 Results and Recent Highlights
Legend Biotech Corporation, a global leader in cell therapy, reported its fourth quarter and full year 2023 unaudited financial results and key corporate highlights.
March 11, 2024
·
16 min read
Business
Legend Biotech Reports Second Quarter 2024 Results and Recent Highlights
August 9, 2024
·
12 min read
1 of 17,841
Next